SCHEMBL4887004

SCHEMBL4887004

O=C(O)c1c(-c2ccccc2)c2cc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)ccc2n1Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 6/20 1.00
NR1I2 O75469 1/20 0.54
PTGDR2 Q9Y5Y4 2/20 0.52
MAPK8 P45983 2/20 0.49
EDNRB P24530 4/20 0.49
EDNRA P25101 4/20 0.49
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.45
UQCRB P14927 1/20 0.44
PPARG P37231 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892537 0.96 SERPINE1 (1.00) SERPINE1NR1I2PTGDR2MAPK8EDNRB
SCHEMBL4893854 0.91 SERPINE1 (1.00) SERPINE1NR1I2MAPK8MEN1MAPT
SCHEMBL4884146 0.88 SERPINE1 (1.00) SERPINE1NR1I2PTGDR2MAPK8EDNRB
SCHEMBL4884301 0.87 SERPINE1 (0.80) SERPINE1MAPK8EDNRBEDNRA
SCHEMBL4980145 0.85 SERPINE1 (0.81) SERPINE1MAPK8EDNRBEDNRAMEN1
SCHEMBL4892523 0.84 SERPINE1 (0.73) SERPINE1NR1I2PTGDR2MAPK8EDNRB
SCHEMBL5437310 0.84 SERPINE1 (0.79) SERPINE1MAPK8EDNRBEDNRAMEN1
SCHEMBL4892528 0.84 SERPINE1 (0.71) SERPINE1NR1I2PTGDR2MAPK8EDNRB
SCHEMBL4891579 0.83 SERPINE1 (0.86) SERPINE1NR1I2PTGDR2MAPK8PPARG
SCHEMBL4891950 0.83 SERPINE1 (0.71) SERPINE1NR1I2PTGDR2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US claimed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US claimed
JP-2007506769-A 2007-03-22 JP claimed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP claimed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US claimed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO claimed
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US disclosed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US disclosed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP disclosed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US disclosed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES STS, TPST2, IDO2 SERPINE1 4706/4885NR1I2 2069/4885PTGDR2 1651/4885
US-20050096377-A1 Substituted sulfonamide-indoles STS, TPST2, IDO2 SERPINE1 4706/4885NR1I2 2069/4885PTGDR2 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.